Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 464
Ph III recruiting: 43
Growth YoY: −9.1%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 151–200 of 507 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01700946	Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma	completed	Phase 2	80	St. Jude Children's Research HospitalOTHER	1	Sep 28, 2022	clinicaltrials
NCT03455140	A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)(PARC)	completed	Phase 1 / Phase 2	49	University of BirminghamOTHER	3	Sep 2, 2022